Rep. Frank Wolf (R-VA) placed two “sensitive but unclassified” (SBU) State Department documents in the Congressional Record last week, illustrating the informal, non-binding character of this information control marking.
Rep. Wolf took to the House floor to express his views on the Council on American-Islamic Relations (CAIR), an advocacy organization that he said had unacceptable links to terrorist groups. CAIR has generally disputed such allegations.
But what is of interest here is Rep. Wolf’s willingness to introduce two State Department cables that are specifically marked “sensitive” and “SBU” and to place them in the public record. Doing so might annoy the State Department and violate unofficial norms of confidentiality, but it breaks no law.
The problematic aspect of SBU and similar labels is that anyone can mark anything “sensitive” or “for official use only” for any reason. The system is completely unregulated. But the flip side is that records bearing such markings are not rigorously protected and in fact are often openly distributed.
As the government moves to replace all kinds of SBU markings with a more uniform “controlled unclassified information” (CUI) system, the expectation is that the standards for applying controls on sensitive but unclassified records will be more clearly articulated, limited and enforced. By the same token, however, the freewheeling disclosure of such records may grind to a halt. It’s hard to know in advance if the benefits in terms of public access to government information will exceed the costs.
With wildfire risk increasing and the potential for destruction along with it continues to grow nationwide, the Federation of American Scientists (FAS) today joins with other organizations to launch a new coalition, Partners in Wildfire Prevention.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.